openPR Logo
Press release

Soft Tissue Sarcoma Market | Key Trends and Opportunity Analysis 2025

08-08-2017 09:59 PM CET | Health & Medicine

Press release from: Transparency Market Research - Pharmaceutical

Soft Tissue Sarcoma Market | Key Trends and Opportunity Analysis

Soft tissues such as muscles, blood vessels, fat, tendons, and lining of the joints connect, support, and surround other body structures. Cancers that originate in these soft tissues are known as soft tissue sarcomas. There are more than 50 types of soft tissue sarcomas, including Kaposi sarcoma, Rhabdomyosarcoma, alveolar soft part sarcoma, adult fibrosarcoma, clear cell sarcoma, liposarcomas, and synovial sarcoma. Common types of soft tissue sarcomas include leiomyosarcoma, abdominal sarcoma, liposarcoma, and undifferentiated pleomorphic sarcoma. According to the American Cancer Society, more than 11,400 new cases of soft tissue sarcoma were diagnosed in the U.S. in 2014. The causes of soft tissue sarcoma are difficult to determine; however, exposure to certain chemicals such as phenoxyacetic herbicides and dioxins; previous exposure to radiotherapy; old age; and certain genetic conditions are anticipated to increase the risk of soft tissue sarcoma. Diagnostic methods used to detect soft tissue sarcoma include PET scan, biopsy, CT scan, and X-ray imaging.

Rise in incidence and prevalence of various types of soft tissue sarcomas, strong focus on research and development to enhance the treatment options available such as targeted therapies and biological therapies, large pipeline of drugs, growth in awareness among people, increase in approvals for the manufacture of generics, and rise in funding for research are some of the factors driving the market. However, side effects associated with cancer treatment, high cost of treatment, stringent government regulations, and high failure rate in clinical trials are likely to hamper the soft tissue sarcoma market in the near future. Additionally, significant shortage of doxorubicin, one of the major drugs employed in chemotherapy, has been reported by the U.S. FDA. The lack of reimbursement for a majority of the registered drugs under the public insurance programs and the lack of availability of many of the oncology drugs in some of the regions might hamper the future market growth.

View Report-

http://www.transparencymarketresearch.com/soft-tissue-sarcoma-market.html

The soft tissue sarcoma market can be segmented based on treatment type, end-user, and geography. In terms of the type of treatment, the market can be divided into chemotherapy, targeted therapy, radiation therapy, and surgery. The chemotherapy treatment segment of the soft tissue sarcoma market generally involves a combination of various anti-cancer drugs. Commonly used drugs include ifosfamide and doxorubicin. Other chemotherapy drugs include dacarbazine, cisplatin, oxaliplatin, paclitaxel, eribulin, and vincristine. Chemotherapy and targeted therapy segments are anticipated to dominate the soft tissue sarcoma market during the forecast period. In terms of end-user, the soft tissue sarcoma market can be classified into multi-specialty hospitals, cancer research centers, ambulatory surgical centers, and others. Multi-specialty hospitals are anticipated to remain dominant during the forecast period.

Based on geography, the soft tissue sarcoma market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. In terms of revenue, North America is anticipated to account for large share of the market during the forecast period. It is likely to be followed by the market in Europe. High incidence rate of soft tissue sarcomas, increase in awareness about soft tissue sarcoma, rise in focus on healthcare, and well-established healthcare infrastructure are some of the factors driving the market in North America. The soft tissue sarcoma market in Asia Pacific is estimated to expand at a high CAGR during the forecast period, led by the increase in government spending on healthcare services in India and China. The market in Latin America and Middle East & Africa is projected to expand during the forecast period, owing to the rise in investments by market players and increase in prevalence of soft tissue sarcomas.

Key players operating in the soft tissue sarcoma market include Genentech USA, Pfizer, Inc., Eli Lilly and Company, Bristol-Myers Squibb, Hoffmann-La Roche Ltd, Johnson & Johnson, Inc., GlaxoSmithKline, Teva Pharmaceuticals, and Celgene Corporation.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Soft Tissue Sarcoma Market during 2017- 2025

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28250

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Soft Tissue Sarcoma Market | Key Trends and Opportunity Analysis 2025 here

News-ID: 660663 • Views:

More Releases from Transparency Market Research - Pharmaceutical

Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Global Neurovascular Devices Market: Overview The global population is aging rapidly. According to WHO, the chances of health risks are greater in geriatric people than the young generation. Old age is considered to be one of the biggest risk factors that are responsible for developing various diseases such as cardiovascular and neurological conditions. It is because of these factors, the global neurovascular devices market is experiencing robust growth in the
Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2026
Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2 …
Transparency Market Research (TMR) has published a new report titled, “Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pneumococcal vaccines market was valued at US$ 7,247.6 Mn in 2017 and is anticipated expand at a CAGR of 3.3% from 2018 to 2026. Increase in patient pool, growth of the pharmaceutical industry, government initiatives to increase vaccination programs, rise
Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from 2020 to 2030
Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from …
Swab and Viral Transport Medium Market: Introduction Transparency Market Research has published a new report titled, ‘Global Swab and Viral Transport Medium Market ’. According to the report, the global swab and viral transport medium market was valued at US$ 0.9 Bn in 2019 and is projected to expand at a CAGR of ~3% from 2020 to 2030. Viral transport medium (VTM) enables safe transfer of viruses, chlamydia, and mycoplasma for
Radiofrequency Ablation Devices Market by Product, Geography and Forecast to 202 …
Transparency Market Research (TMR) has published a new report titled, 'Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global radiofrequency ablation devices for pain management market was valued at US$ 543.0 Mn in 2018 and is projected to expand at a CAGR of above 11.0% from 2019 to 2027. Overview Radiofrequency ablation is a minimally invasive surgical

All 5 Releases


More Releases for America

Waterproof Labels Market Outlook, Supportive Judgments | SATO America, LANGGUTH …
Report Ocean recently published a new report on the Global Waterproof Labels Market. The study has an in-depth analysis of the forecast period from 2021-2025. The report reveals a comprehensive picture of the Waterproof Labels Market situation, taking into consideration all major trends, market dynamics, and competitive factors. Additionally, the report contains key statistics concerning the Waterproof Labels Market situation of the leading key players, key market trends, and potential
Textiles Market Analysis Report, Regional Outlook - Europe, North America, South …
Adroit Market Research has announced the addition of the “Global Textiles Market Size Status and Forecast 2025”, The report classifies the global Textiles in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report studies the global Textiles Speaker market, analyzes and researches the Textiles Speaker development status and forecast in Europe, North America, Central America, South America, Asia Pacific
Blow Molding Machinery Market Analysis Report, Regional Outlook - Europe, North …
Adroit Market Research has announced the addition of the “Global Blow Molding Machinery Market Size Status and Forecast 2025”, The report classifies the global Blow Molding Machinery in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report studies the global Blow Molding Machinery Speaker market, analyzes and researches the Blow Molding Machinery Speaker development status and forecast in Europe,
Global Gaucher Disease Market 2018 Covering North America, South America, Europe
Gaucher Disease Market Summary The Global Gaucher Disease Market is defined by the presence of some of the leading competitors operating in the market, including the well-established players and new entrants, and the suppliers, vendors, and distributors. The key players are continuously focusing on expanding their geographic reach and broadening their customer base, in order to expand their product portfolio and come up with new advancements. Gaucher Disease market size to maintain the average annual growth
Epigenetics Market by End Users, and by Geography North America, Latin America, …
Increasing research to study the epigenetics of the genome (study called epigenomics) is expected to boost growth of the epigenetics market over the forecast period. Genome-wide epigenetic studies play an important role in the diagnostics of human diseases. Moreover, implementation of epigenetics for oncology research is estimated to propel the growth of epigenetics market. For instance, Constellation Pharmaceuticals, in April 2018, invested US$ 100 million for development of cancer epigenetics
Spas and Beauty Salons Market - South America, Central America and North America …
Consumers’ changing perception towards personal care coupled with continuous strive to improve general well-being are generating a positive impact on the spas and beauty salons industry. Growing consumer need to improve personal appearance and well-being has increased the demand for wellness solutions. Spa centers and beauty salons, in order to meet the increasing demand for unique spa and beauty services, are constantly striving to improve their services by focusing on